Abstract
Sarains are diamide alkaloids isolated from the Mediterranean sponge Haliclona (Rhizoniera) sarai that have previously shown antibacterial, insecticidal and anti-fouling activities. In this study, we examined for the first time the neuroprotective effects of sarains 1, 2 and A against oxidative stress in a human neuronal model. SH-SY5Y cells were co-incubated with sarains at concentrations ranging from 0.01 to 10 μM, and the well-known oxidant hydrogen peroxide at 150 μM for 6 h and the protective effects of the compounds were evaluated. Among the sarains tested, sarain A was the most promising compound, improving mitochondrial function and decreasing reactive oxygen species levels in human neuroblastoma cells treated with the compound at 0.01, 0.1 and 1 μM. This compound was also able to increase the activity of the antioxidant enzymes superoxide dismutases by inducing the translocation of the nuclear factor E2-related factor 2 (Nrf2) to the nucleus at the lower concentrations tested (0.01 and 0.1 μM). Moreover, sarain A at 0.1 and 1 μM blocked the mitochondrial permeability transition pore (mPTP) opening through cyclophilin D inhibition. These results suggest that the protective effects produced by the treatment with sarain A are related with its ability to block the mPTP and to enhance the Nrf2 pathway, indicating that sarain A may be a candidate compound for further studies in neurodegenerative diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baines CP et al (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658–662. doi:10.1038/nature03434
Blanquer-Rossello MD, Hernandez-Lopez R, Roca P, Oliver J, Valle A (2017) Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells. Biochim Biophys Acta 1861:431–440. doi:10.1016/j.bbagen.2016.10.009
Blihoghe D, Manzo E, Villela A, Cutignano A, Picariello G, Faimali M, Fontana A (2011) Evaluation of the antifouling properties of 3-alyklpyridine compounds. Biofouling 27:99–109. doi:10.1080/08927014.2010.542587
Burchell VS, Gandhi S, Deas E, Wood NW, Abramov AY, Plun-Favreau H (2010) Targeting mitochondrial dysfunction in neurodegenerative disease: part I. Expert Opin Ther Targets 14:369–385. doi:10.1517/14728221003652489
Butterfield DA, Hardas SS, Lange ML (2010) Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer’s disease: many pathways to neurodegeneration. J Alzheimers Dis 20:369–393. doi:10.3233/jad-2010-1375
Calkins MJ et al (2009) The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal 11:497–508. doi:10.1089/ARS.2008.2242
Caprioli V, Cimino G, De Giulio A, Madaio A, Scognamiglio G, Trivellone E (1992) Selected biological activities of saraines. Comp Biochem Physiol B 103:293–296
Cardoso S, Seica RM, Moreira PI (2017) Mitochondria as a target for neuroprotection: implications for Alzheimer’s disease. Expert Rev Neurother 17:77–91 doi:10.1080/14737175.2016.1205488
Chakraborty TR, Cohen J, Yohanan D, Alicea E, Weeks BS, Chakraborty S (2016) Estrogen is neuroprotective against hypoglycemic injury in murine N38 hypothalamic cells. Mol Med Rep 14:5677–5684. doi:10.3892/mmr.2016.5952
Cimino G, Stefano SD, Scognamiglio G, Sodano G, Trivellone E (1986) Sarains: a new class of alkaloids from the marine sponge Reniera Sarai. Bulletin des Sociétés Chimiques Belges 95:783–800. doi:10.1002/bscb.19860950907
Cimino G, Mattia CA, Mazzarella L, Putili R, Scognamiglio G, Spinella A, Trivellone E (1989) Unprecedented alkaloid skeleton from the mediterranean sponge reniera sarai: X-ray structure of an acetate derivative of sarain-a. Tetrahedron 45:3863–3872 doi:10.1016/S0040-4020(01)89245-0
Clarke SJ, McStay GP, Halestrap AP (2002) Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin. A J Biol Chem 277:34793–34799. doi:10.1074/jbc.M202191200
Coccini T, Manzo L, Bellotti V, De Simone U (2014) Assessment of cellular responses after short- and long-term exposure to silver nanoparticles in human neuroblastoma (SH-SY5Y) and astrocytoma (D384) cells. ScientificWorldJournal 2014:259765. doi:10.1155/2014/259765
Connern CP, Halestrap AP (1994) Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem J 302(Pt 2):321–324
Corona JC, Duchen MR (2015) Impaired mitochondrial homeostasis and neurodegeneration: towards new therapeutic targets? J Bioenerg Biomembr 47(1–2):89–99. doi:10.1007/s10863-014-9576-6
Crompton M, Costi A (1988) Kinetic evidence for a heart mitochondrial pore activated by Ca2+, inorganic phosphate and oxidative stress. A potential mechanism for mitochondrial dysfunction during cellular Ca2+ overload. Eur J Biochem 178:489–501
Defant A, Mancini I, Raspor L, Guella G, Turk T, Sepčić K (2011) New structural insights into Saraines A, B, and C, macrocyclic alkaloids from the Mediterranean sponge Reniera (Haliclona) sarai. Eur J Org Chem 2011:3761–3767. doi:10.1002/ejoc.201100434
Di Domenico F, Barone E, Perluigi M, Butterfield DA (2015) Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants. Expert Rev Neurother 15:19–40. doi:10.1586/14737175.2015.955853
Du H, Yan SS (2010) Mitochondrial permeability transition pore in Alzheimer’s disease: cyclophilin D and amyloid beta. Biochim Biophys Acta 1802:198–204. doi:10.1016/j.bbadis.2009.07.005
Du H et al (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease. Nat Med 14:1097–1105. doi:10.1038/nm.1868
Eliseev RA, Filippov G, Velos J, Van Winkle B, Goldman A, Rosier RN, Gunter TE (2007) Role of cyclophilin D in the resistance of brain mitochondria to the permeability transition. Neurobiol Aging 28:1532–1542. doi:10.1016/j.neurobiolaging.2006.06.022
Esteras N, Dinkova-Kostova AT, Abramov AY (2016) Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function. Biol Chem 397:383–400. doi:10.1515/hsz-2015-0295
Fischer G, Bang H, Berger E, Schellenberger A (1984) Conformational specificity of chymotrypsin toward proline-containing substrates. Biochim Biophys Acta 791:87–97
Gandhi S, Abramov AY (2012) Mechanism of oxidative stress in neurodegeneration. Oxidative Med Cell Longev 2012:428010. doi:10.1155/2012/428010
Gregory MA et al (2011) Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin family. Antimicrob Agents Chemother 55:1975–1981. doi:10.1128/aac.01627-10
Grosso C, Valentão P, Ferreres F, Andrade PB (2014) Bioactive marine drugs and marine biomaterials for brain diseases. Mar Drugs 12:2539–2589. doi:10.3390/md12052539
Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231–255. doi:10.1038/sj.bjp.0705776
Hansson MJ, Persson T, Friberg H, Keep MF, Rees A, Wieloch T, Elmer E (2003) Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res 960:99–111
Holmstrom KM et al (2013) Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol Open 2:761–770. doi:10.1242/bio.20134853
Huang SL, He HB, Zou K, Bai CH, Xue YH, Wang JZ, Chen JF (2014) Protective effect of tomatine against hydrogen peroxide-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells. J Pharm Pharmacol 66:844–854. doi:10.1111/jphp.12205
Itoh K, Ye P, Matsumiya T, Tanji K, Ozaki T (2015) Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria. J Clin Biochem Nutr 56:91–97. doi:10.3164/jcbn.14-134
Kharroubi W, Nury T, Ahmed SH, Andreoletti P, Sakly R, Hammami M, Lizard G (2017) Induction by arsenate of cell-type-specific cytotoxic effects in nerve and hepatoma cells. Hum Exp Toxicol. doi:10.1177/0960327116687893
Kumar A, Singh A (2015) A review on mitochondrial restorative mechanism of antioxidants in Alzheimer’s disease and other neurological conditions. Front Pharmacol 6:206. doi:10.3389/fphar.2015.00206
Lee J (2016) Mitochondrial drug targets in neurodegenerative diseases. Bioorg Med Chem Lett 26:714–720. doi:10.1016/j.bmcl.2015.11.032
Leirós M et al (2015) Gracilins: spongionella-derived promising compounds for Alzheimer disease. Neuropharmacology 93:285–293. doi:10.1016/j.neuropharm.2015.02.015
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–795. doi:10.1038/nature05292
Lu MC, Ji JA, Jiang ZY, You QD (2016) The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update. Med Res Rev 36:924–963. doi:10.1002/med.21396
Magesh S, Chen Y, Hu L (2012) Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev 32:687–726. doi:10.1002/med.21257
Malhotra D et al (2010) Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38:5718–5734. doi:10.1093/nar/gkq212
McBean GJ, Lopez MG, Wallner FK (2016) Redox-based therapeutics in neurodegenerative disease. Br J Pharmacol. doi:10.1111/bph.13551
Moreira PI et al (2010) Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 1802:212–220. doi:10.1016/j.bbadis.2009.10.007
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Nguyen TT, Stevens MV, Kohr M, Steenbergen C, Sack MN, Murphy E (2011) Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem 286:40184–40192. doi:10.1074/jbc.M111.243469
Ouazia D, Levros LC Jr, Rassart E, Desrosiers RR (2014) Dopamine down-regulation of protein L-isoaspartyl methyltransferase is dependent on reactive oxygen species in SH-SY5Y cells. Neuroscience 267:263–276. doi:10.1016/j.neuroscience.2014.03.001
Park SY, Kim DY, Kang JK, Park G, Choi YW (2014) Involvement of activation of the Nrf2/ARE pathway in protection against 6-OHDA-induced SH-SY5Y cell death by alpha-iso-cubebenol. Neurotoxicology 44:160–168. doi:10.1016/j.neuro.2014.06.011
Pertega-Gomes N et al (2015) A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. J Pathol 236:517–530. doi:10.1002/path.4547
Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P, Di Lisa F (1999) Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 76:725–734. doi:10.1016/s0006-3495(99)77239-5
Ramsey CP et al (2007) Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 66:75–85. doi:10.1097/nen.0b013e31802d6da9
Rao VK, Carlson EA, Yan SS (2014) Mitochondrial permeability transition pore is a potential drug target for neurodegeneration. Biochim Biophys Acta 1842:1267–1272. doi:10.1016/j.bbadis.2013.09.003
Sasaki S, Tozawa T, Van Wagoner RM, Ireland CM, Harper MK, Satoh T (2011) Strongylophorine-8, a pro-electrophilic compound from the marine sponge Petrosia (strongylophora) corticata, provides neuroprotection through Nrf2/ARE pathway. Biochem Biophys Res Commun 415:6–10. doi:10.1016/j.bbrc.2011.09.114
Singh A et al (2013) Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J Clin Invest 123:2921–2934. doi:10.1172/jci66353
Tricarico PM, de Oliveira Franca RF, Pacor S, Ceglia V, Crovella S, Celsi F (2016) HIV protease inhibitors apoptotic effect in SH-SY5Y neuronal cell line. Cell Physiol Biochem 39:1463–1470. doi:10.1159/000447849
Vega-Avila E, Pugsley MK (2011) An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. Proc West Pharmacol Soc 54:10–14
Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta 1842:1240–1247. doi:10.1016/j.bbadis.2013.10.015
Weidinger A, Kozlov AV (2015) Biological activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction. Biomol Ther 5:472–484. doi:10.3390/biom5020472
Yan MH, Wang X, Zhu X (2013) Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med 62:90–101. doi:10.1016/j.freeradbiomed.2012.11.014
Yan W et al (2015) Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition. Bioorg Med Chem Lett 25:5682–5686. doi:10.1016/j.bmcl.2015.11.002
Zhang HA et al (2012) Salvianolic acid A protects human SH-SY5Y neuroblastoma cells against H(2)O(2)-induced injury by increasing stress tolerance ability. Biochem Biophys Res Commun 421:479–483. doi:10.1016/j.bbrc.2012.04.021
Zhou X, Zheng W, Nagana Gowda GA, Raftery D, Donkin SS, Bequette B, Teegarden D (2016) 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell. J Steroid Biochem Mol Biol 163:147–156. doi:10.1016/j.jsbmb.2016.04.022
Acknowledgments
The research leading to these results has received funding from the following FEDER cofunded-grants. From CDTI and Technological Funds, supported by Ministerio de Economía, Industria y Competitividad, AGL2014-58210-R, AGL2016-78728-R (AEI/FEDER, UE), ISCIII/PI16/01830 and RTC-2016-5507-2. From CDTI under ISIP Programme, Spain, IDI-20130304 APTAFOOD and ITC-20161072. From the European Union’s Seventh Framework Programme managed by REA – Research Executive Agency (FP7/2007-2013) under grant agreement 312184 PHARMASEA.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Alvariño, R., Alonso, E., Tribalat, MA. et al. Evaluation of the Protective Effects of Sarains on H2O2-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Neuroblastoma Cells. Neurotox Res 32, 368–380 (2017). https://doi.org/10.1007/s12640-017-9748-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-017-9748-3